HighRes Biosolutions

Current leadership (1)

• Peter Harris ceosecondary-verified

Safety record

No incidents on record for HighRes Biosolutions.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Financial state

Reporting basis

aggregator_estimate

Lifecycle stage

early

Counterparty risk class

unknown

Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.

Timeline

Every recorded move in HighRes Biosolutions’s history, most recent first: funding rounds, partnerships, acquisitions, supply-chain starts, key hires, and press.

1. 🤝

   PartnershipHighRes x Opentrons (AI Agent Lab Automation)

   2026-02-04

   HighRes and Opentrons announced a strategic partnership to co-develop the industry's first AI agent-to-agent laboratory workflow. The collaboration unites Opentrons Flex robotic platforms with HighRes FlexPod and Cellario orchestration software enabling scientists to adopt automation quickly and scale seamlessly.

2. 🤝

   PartnershipHighRes x Liverpool School of Tropical Medicine (AI Infection Labs)

   2025-04-28

   HighRes Biosolutions was selected as the automation partner for Liverpool School of Tropical Medicine and the Infection Innovation Consortium to power a 20 million robotic AI laboratory for infection R&D. The facility is designed to transform infection research through automated workflows.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

• Record createdJun 7, 2026

  Added to the verified registry

Full change history →

Sources (2)

1. https://www.highresbio.com/ ↗
2. https://www.highresbio.com/products/cellario ↗

Common questions